Scienjoy
Scienjoy's revenue fell 8.9% to CN¥1.2 billion in fiscal 2025. Its operating margin was −6.3%, down from 3.0% a year earlier. Free cash flow was CN¥70 million, up 2.9%. The diluted share count rose 0.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity.
Income statement
From fiscal 2018 to 2024, earnings per share fell 25.0% a year and net income 15.2% a year, as new shares raised the share count by 108% and diluted each share's earnings. Scienjoy then lost money in fiscal 2025.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 280 | 216 | 237 | 290 | 316 |
| Debt incl. finance leases | 8 | 15 | 16 | — | — |
| Net debt (negative means net cash) | −272 | −201 | −221 | — | — |
| Net debt to EBITDA | −1.6x | −1.3x | −7.1x | — | — |
| Debt to equity | 0.0x | 0.0x | 0.0x | — | — |
| Interest coverage | — | — | — | — | — |
| Current ratio | 3.0x | 2.4x | 2.5x | 3.4x | 3.6x |
| Quick ratio | 3.0x | 2.4x | 2.5x | 3.4x | 3.6x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | — | — |
| Rule of 40 | −18.0% | −2.0% | −3.3% |
| Altman Z'' | 7.11 | 9.18 | 7.56 |
| Accruals ratio | −9.1% | −2.0% | −62.2% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Pass | Fail |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | — | — |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 4 of 9 | — | — |
Compare
Put Scienjoy side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Scienjoy | FY25 | −8.9% | −6.3% | 5.6% | — | — | — | |
| ZoomInfo | FY25 | 2.9% | 18.1% | 31.2% | 5.3% | 3.6x | 7 | Compare |
| Sportradar Group AG | FY25 | 16.6% | — | 30.9% | 26.6% | −1.1x | — | Compare |
| QuinStreet | FY26 | 18.3% | 2.7% | 9.9% | 17.4% | −1.0x | 7 | Compare |
| MediaAlpha | FY25 | 28.8% | 2.0% | 5.9% | 23.3% | 4.2x | 4 | Compare |
8 years of figures
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 743 | 915 | 1,222 | 1,669 | 1,953 | 1,465 | 1,363 | 1,242 |
| Revenue growth | — | 23.1% | 33.6% | 36.6% | 17.0% | −25.0% | −6.9% | −8.9% |
| Gross profit | 149 | 194 | 262 | 304 | 283 | 193 | 245 | 227 |
| Research and development | 11 | 22 | 32 | 70 | 68 | 75 | 90 | 83 |
| Operating income | — | — | — | 166 | 150 | 23 | 41 | −79 |
| Net income | 107 | 150 | 176 | 170 | 193 | −31 | 40 | −587 |
| Diluted EPS (CNY) | 5.34 | 7.50 | 6.56 | 5.51 | 4.92 | −0.76 | 0.95 | −14.05 |
| Diluted shares (millions) | 20 | 20 | 27 | 31 | 39 | 41 | 42 | 42 |
| Cash flow | ||||||||
| Cash from operations | 107 | 229 | 155 | 116 | 58 | 103 | 69 | 70 |
| Capital expenditure | 1 | 0 | 1 | 1 | 2 | 0 | 1 | 1 |
| Free cash flow | 107 | 228 | 154 | 115 | 55 | 102 | 68 | 70 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 16 | 3 | 1 | 0 |
| Acquisitions | 0 | 0 | 0 | 280 | 0 | 4 | 0 | 1 |
| Stock-based compensation | — | — | — | 32 | 12 | 14 | 11 | 8 |
| Balance sheet at fiscal year end | ||||||||
| Cash and short-term investments | 65 | 137 | 225 | 280 | 216 | 237 | 290 | 316 |
| Debt incl. finance leases | — | — | — | 8 | 15 | 16 | — | — |
| Total assets | — | 280 | 812 | 1,089 | 1,502 | 1,448 | 1,405 | 710 |
| Total liabilities | — | 106 | 352 | 280 | 340 | 299 | 220 | 117 |
| Shareholders' equity | 57 | 174 | 460 | 809 | 1,161 | 1,151 | 1,199 | 615 |
| Margins and ratios | ||||||||
| Gross margin | 20.0% | 21.2% | 21.5% | 18.2% | 14.5% | 13.2% | 18.0% | 18.3% |
| Operating margin | — | — | — | 9.9% | 7.7% | 1.6% | 3.0% | −6.3% |
| Net margin | 14.4% | 16.4% | 14.4% | 10.2% | 9.9% | −2.1% | 2.9% | −47.3% |
| Free cash flow margin | 14.4% | 25.0% | 12.6% | 6.9% | 2.8% | 7.0% | 5.0% | 5.6% |
| Rule of 40 (growth + FCF margin) | — | 48.1% | 46.3% | 43.5% | 19.8% | −18.0% | −2.0% | −3.3% |
| Return on capital | — | — | — | — | 18.3% | 1.9% | — | — |
| Return on equity | — | — | 55.5% | 26.8% | 19.6% | −2.7% | 3.4% | −64.7% |
| Return on assets | — | — | 32.3% | 17.9% | 14.9% | −2.1% | 2.8% | −55.5% |
| Net debt to EBITDA | — | — | — | −1.6x | −1.3x | −7.1x | — | — |